{"id":360168,"date":"2023-06-19T09:58:11","date_gmt":"2023-06-19T07:58:11","guid":{"rendered":"https:\/\/medizinonline.com\/covid-19-in-everyday-practice-the-treatment-option-with-paxlovid\/"},"modified":"2023-06-19T13:37:41","modified_gmt":"2023-06-19T11:37:41","slug":"covid-19-in-everyday-practice-the-treatment-option-with-paxlovid","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/covid-19-in-everyday-practice-the-treatment-option-with-paxlovid\/","title":{"rendered":"COVID-19 in everyday practice: the treatment option with PAXLOVID\u00ae."},"content":{"rendered":"\n<p><strong>Antiviral medications may be used in COVID-19 patient:s at increased risk for severe disease progression.<sup>1, 2<\/sup> The antiviral PAXLOVID\u00ae (nirmatrelvir  [PF-07321332]  \/ ritonavir) is the only oral COVID-19 therapy approved and recommended in Switzerland.<sup>2-4<\/sup> The five-day treatment can be dispensed by all pharmacies on prescription and by self-dispensing physicians directly and should be used as soon as possible after a positive viral test for SARS-CoV-2.<sup>1-3<\/sup><\/strong><\/p>\n\n<!--more-->\n\n<p>In the webcast, PD Dominique Braun, MD, senior physician with expanded responsibilities at the Department of Infectious Diseases and Hospital Hygiene at University Hospital Zurich, presents antiviral therapy for COVID-19 in Switzerland, and Prof. Catia Marzolini, pharmacologist at the Universities of Liverpool and Basel and scientific director of the  <a href=\"https:\/\/www.covid19-druginteractions.org\/\" target=\"_blank\" rel=\"noopener\">COVID-19 drug interaction checker<\/a><sup>5<\/sup>, indicates what you should be aware of regarding drug interactions with PAXLOVID\u00ae.  <\/p>\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"2023-03-16_Webinar_COVID_19_im_Praxisalltag__die_Behandlungsm\u00f6glichkeit_mit_PAXLOVID_JBe_2.3\" data-src=\"https:\/\/player.vimeo.com\/video\/822993573?dnt=1&amp;app_id=122963\" width=\"1160\" height=\"653\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe>\n<\/div><figcaption class=\"wp-element-caption\">webcast dr. braun &amp; prof. marzolini<\/figcaption><\/figure>\n\n<p><strong>References<\/strong><\/p>\n\n<p>1. Federal Office of Public Health FOPH, Coordination of Supply of Covid 19 Essential Medicines, <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html,<\/a> last accessed Feb. 20 <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">,<\/a> 2023<em>.<\/em><br\/>2. Swiss Society of Infectious Diseases (SSI). Recommendations on early use of covid-19 therapies and prophylaxis prepared by the Swiss Society of Infectious<em> Diseases<\/em> (SSI), Feb 06, 2023 <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html,<\/a> last accessed Feb 20, 2023.<br\/>3. PAXLOVID\u00ae (nirmatrelvir [PF-07321332] and ritonavir): current product information available at <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch<\/a>.<br\/>4. list of approved drugs in Switzerland <a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/listen_neu.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/listen_neu.html,<\/a> last accessed 20.02.2023.<br\/>5. COVID-19 Drug Interactions, <a href=\"https:\/\/www.covid19-druginteractions.org\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.covid19-druginteractions.org\/,<\/a> last accessed 04\/26\/2023<em>.<\/em><\/p>\n\n<p>The references are available on request. <\/p>\n\n<p><a href=\"https:\/\/medizinonline.com\/en\/brief-subject-information\/\" target=\"_blank\" rel=\"noreferrer noopener\">The abbreviated technical information on PAXLOVID\u00ae  <\/a><\/p>\n\n<p>The current technical information of PAXLOVID\u00ae can be found at <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch<\/a>.<\/p>\n\n<p>\u25bc This medicinal product is subject to additional monitoring. For further information, please see the PAXLOVID\u00ae expert\/patient information leaflet at <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch<\/a>.<\/p>\n\n<p>Responsible for the content and financed by: Pfizer AG, Sch\u00e4renmoosstrasse 99, 8052 Zurich  <\/p>\n\n<p>PP-PAX-CHE-0240 April 2023<\/p>\n\n<p>Post online since 19.09.2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Antiviral medications may be used in COVID-19 patient:s at increased risk for severe disease progression.1, 2 The antiviral PAXLOVID\u00ae (nirmatrelvir [PF-07321332] \/ ritonavir) is the only oral COVID-19 therapy approved&hellip;<\/p>\n","protected":false},"author":14,"featured_media":360173,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Webcast Dr. Braun & Prof. Marzolini","footnotes":""},"category":[11406,11323,11548],"tags":[69123],"powerkit_post_featured":[],"class_list":["post-360168","post","type-post","status-publish","format-standard","has-post-thumbnail","category-infectiology","category-partner-content-en","category-rx-en","tag-webcast-en","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-19 09:47:05","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":360171,"slug":"covid-19-dans-la-pratique-quotidienne-la-possibilite-de-traitement-avec-paxlovid","post_title":"COVID-19 dans la pratique quotidienne : la possibilit\u00e9 de traitement avec PAXLOVID\u00ae.","href":"https:\/\/medizinonline.com\/fr\/covid-19-dans-la-pratique-quotidienne-la-possibilite-de-traitement-avec-paxlovid\/"},"it_IT":{"locale":"it_IT","id":360172,"slug":"la-covid-19-nella-pratica-quotidiana-lopzione-di-trattamento-con-paxlovid","post_title":"La COVID-19 nella pratica quotidiana: l'opzione di trattamento con PAXLOVID\u00ae","href":"https:\/\/medizinonline.com\/it\/la-covid-19-nella-pratica-quotidiana-lopzione-di-trattamento-con-paxlovid\/"},"pt_PT":{"locale":"pt_PT","id":360170,"slug":"covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid","post_title":"COVID-19 na pr\u00e1tica quotidiana: a op\u00e7\u00e3o de tratamento com PAXLOVID\u00ae","href":"https:\/\/medizinonline.com\/pt-pt\/covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid\/"},"es_ES":{"locale":"es_ES","id":360169,"slug":"covid-19-en-la-practica-diaria-la-opcion-de-tratamiento-con-paxlovid","post_title":"COVID-19 en la pr\u00e1ctica diaria: la opci\u00f3n de tratamiento con PAXLOVID","href":"https:\/\/medizinonline.com\/es\/covid-19-en-la-practica-diaria-la-opcion-de-tratamiento-con-paxlovid\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/360168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=360168"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/360168\/revisions"}],"predecessor-version":[{"id":360175,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/360168\/revisions\/360175"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/360173"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=360168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=360168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=360168"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=360168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}